• Total revenue of $38.4 million, up 23% year-over-year
  • Services revenue growth of 39% was driven by the 110% year-over-year increase in subscription revenue
  • Total deferred revenue at June 30, 2014 increased 33% year-over-year to $64.1 million

REDWOOD SHORES, Calif.–(BUSINESS WIRE)–Jul. 31, 2014– Imperva, Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced financial results for the second quarter ended June 30, 2014.

“We were pleased with our execution during the second quarter and our ability to exceed guidance,” stated Shlomo Kramer, President and Chief Executive Officer of Imperva. “During the quarter, we made good progress on the productivity initiatives we began to implement last quarter highlighted by a rebound in the United States as well as a continuation of our overall high win rates globally. We believe that Imperva is well positioned to maintain its momentum during the second half of the year due to the combination of ongoing demand for our integrated solution, strong growth of subscriptions and growing pipeline of opportunities globally.”

Second Quarter 2014 Financial Highlights

  • Revenue: Total revenue for the second quarter of 2014 was $38.4 million, an increase of 23% compared to $31.3 million in the second quarter of 2013. Within total revenue, product revenue was $16.6 million compared to $15.7 million in the same period last year. Services revenue increased 39% year-over-year to $21.9 million and accounted for 57% of total revenue, up from 50% in the second quarter of 2013. Within services revenue, overall subscription revenue grew 110% to $5.3 million, compared to the second quarter of 2013. Combined product and subscriptions revenue was $21.8 million compared to $18.2 million in the second quarter of 2013.
  • Operating Profit (Loss): Operating loss as reported in accordance with U.S. generally accepted accounting principles (GAAP) was $(15.3) million for the second quarter compared to a loss of $(5.7) million during the second quarter in 2013. GAAP results included stock-based compensation expense of $8.7 million for the second quarter of 2014 and $3.6 million for the second quarter of 2013. GAAP results also included amortization of intangibles of $0.4 million during the second quarter of 2014. Non-GAAP operating loss for the second quarter was $(6.2) million, compared to a loss of $(2.1) million during the same period in 2013, excluding the above mentioned charges.
  • Net Profit (Loss): GAAP net loss attributable to Imperva stockholders for the second quarter was $(15.4) million, or $(0.60) per share based on 25.8 million weighted average shares outstanding. This compares to GAAP net loss attributable to Imperva stockholders of $(5.9) million, or $(0.24) per share based on 24.2 million weighted average shares outstanding in the prior-year period.

    Non-GAAP net loss attributable to Imperva stockholders for the second quarter of 2014 was $(6.4) million, or $(0.25) per share based on 25.8 million weighted average shares outstanding, excluding the above mentioned charges. This compares to non-GAAP net loss attributable to Imperva stockholders of $(2.3) million, or $(0.10) per share based on 24.2 million weighted average diluted shares outstanding in the prior-year period.

    A reconciliation of GAAP to non-GAAP financial measures has been provided in the financial statement tables included in this press release. An explanation of these measures is also included below under the heading “Non-GAAP Financial Measures.”

  • Balance Sheet: As of June 30, 2014, Imperva had cash, cash equivalents and investments of $99.5 million. Total deferred revenue of $64.1 million increased 33% compared to $48.3 million as of June 30, 2013.

Second Quarter 2014 Operating Highlights

  • During the second quarter of 2014, Imperva booked 88 deals with a value over $100,000 compared to 76 deals during the second quarter of last year. During the six months ended June 30, 2014, Imperva booked 155 deals with a value over $100,000 compared to 140 during the same period in 2013.
  • During the second quarter of 2014, Imperva added 175 new customers compared to 185 during the second quarter of last year. During the six months ended June 30, 2014, Imperva added 346 new customers compared to 333 during the same period in 2013. Imperva now has over 3,300 customers in more than 75 countries around the world.

Business Outlook

The following forward-looking statements reflect expectations as of July 31, 2014. Results may be materially different and could be affected by the factors detailed in this press release and in recent Imperva SEC filings.

Third Quarter Expectations – Ending September 30, 2014

Imperva expects total revenue for the third quarter of 2014 to be in the range of $38.0 million to $41.0 million, representing growth in the range of 8% to 17% compared to the same period in 2013. The company expects in the third quarter of 2014 non-GAAP gross margins of approximately 78.5%. Further, Imperva expects in the third quarter of 2014 non-GAAP operating loss to be in the range of $(6.0) million to $(8.0) million and non-GAAP net loss attributable to Imperva stockholders to be in the range of $(6.5) million to $(8.5) million, or a loss of $(0.25) to $(0.33) per share based on approximately 26.0 million weighted average shares, which excludes stock-based compensation expense and amortization of intangibles.

Full Year Expectations –Ending December 31, 2014

Imperva expects total revenue for 2014 to be in the range of $155.5 million to $162.5 million, or up 13% to 18% compared to 2013. Imperva expects 2014 non-GAAP gross margins of approximately 79%. Further, the company expects 2014 non-GAAP operating loss to be in the range of $(21.0) million to $(26.5) million and non-GAAP net loss attributable to Imperva stockholders to be in the range of $(21.5) million to $(27.5) million, or a loss of $(0.83) to $(1.06) per share based on approximately 26.0 million weighted average shares, which excludes stock-based compensation, amortization of intangibles and acquisition-related expenses. Imperva expects capital expenditures for the full year to be in the range of $3.5 million to $4.5 million. Finally, the company expects to generate negative cash flows from operations in 2014.

Quarterly Conference Call

Imperva will host a conference call today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to review the company’s financial results for the second quarter ended June 30, 2014. To access this call, dial 877.879.6203 for the U.S. and Canada or 719.325.4800 for international callers with conference ID #5315327. A live webcast of the conference call will be accessible from the investors page of Imperva’s website at www.imperva.com, and a recording will be archived and accessible at www.imperva.com. An audio replay of this conference call will also be available through August 14, 2014, by dialing 877.870.5176 for the U.S. and Canada, or 858.384.5517 for international callers and entering passcode #5315327.

Non-GAAP Financial Measures

Imperva reports all financial information required in accordance with U.S. generally accepted accounting principles (GAAP). To supplement the Imperva unaudited condensed consolidated financial statements presented in accordance with GAAP, Imperva uses certain non-GAAP measures of financial performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from, as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the results of Imperva operations as determined in accordance with GAAP. The non-GAAP financial measures used by Imperva include historical non-GAAP net loss and non-GAAP basic and diluted loss per share. These non-GAAP financial measures exclude stock-based compensation, amortization of intangibles and acquisition-related expenses from the Imperva unaudited condensed consolidated statement of operations.

For a description of these items, including the reasons why management adjusts for them, and reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures, please see the section of the accompanying tables titled “Use of Non-GAAP Financial Information” as well as the related tables that precede it. Imperva may consider whether other significant non-recurring items that arise in the future should also be excluded in calculating the non-GAAP financial measures it uses.

Imperva believes that these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provide meaningful supplemental information regarding the performance of Imperva by excluding certain items that may not be indicative of the company’s core business, operating results or future outlook. Imperva management uses, and believes that investors benefit from referring to, these non-GAAP financial measures in assessing operating results of Imperva, as well as when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate comparisons of the performance of Imperva to prior periods.

Forward Looking Statements

This press release contains forward-looking statements, including without limitation those regarding Imperva’s “Business Outlook” (“Third Quarter Expectations – Ending September 30, 2014” and “Full Year Expectations – Ending December 31, 2014”); Imperva’s belief that it is in position to maintain its momentum during the second half of the year; and the company’s expectations regarding ongoing demand for its integrated solution. These forward-looking statements are subject to material risks and uncertainties that may cause actual results to differ substantially from expectations. Investors should consider important risk factors, which include: the risk that the steps the company has taken and plans to take to address its sales execution challenges may prove insufficient; the risk that demand for the company’s data center security solutions may not increase and may decrease; the risk that Imperva may not timely introduce new products or versions of its products and that they may not be accepted by the market; the risk that competitors may be perceived by customers to be better positioned to help handle business security threats and protect their businesses from major risk; the risk that the growth of Imperva may be lower than anticipated; and other risks detailed under the caption “Risk Factors” in the company’s Form 10-Q filed with the Securities and Exchange Commission, or the SEC, on May 9, 2014 and the company’s other SEC filings. You can obtain copies of the company’s SEC filings on the SEC’s website at www.sec.gov.

The foregoing information represents the company’s outlook only as of the date of this press release, and Imperva undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, new developments or otherwise.

About Imperva

Imperva, pioneering the third pillar of enterprise security, fills the gaps in endpoint and network security by directly protecting high-value applications and data assets in physical and virtual data centers. With an integrated security platform built specifically for modern threats, Imperva data center security provides the visibility and control needed to neutralize attack, theft, and fraud from inside and outside the organization, mitigate risk, and streamline compliance. Over 3,300 customers in more than 75 countries rely on our SecureSphere® platform to safeguard their business. Imperva is headquartered in Redwood Shores, California. Learn more: www.imperva.com, our blog, on Twitter.

© 2014 Imperva, Inc. All rights reserved. Imperva, the Imperva logo, and SecureSphere are trademarks of Imperva, Inc.

 
IMPERVA, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(On a GAAP basis)
(In thousands, except per share amounts)
(Unaudited)
       
 
For the Three Months Ended For the Six Months Ended
Jun 30 Jun 30 Jun 30 Jun 30
  2014   2013   2014   2013
 
Net revenue:
Products and license $ 16,586 $ 15,671 $ 28,557 $ 29,825
Services   21,856   15,668   41,401   30,099
Total net revenue 38,442 31,339 69,958 59,924
Cost of revenue(1):
Products and license 2,075 2,446 3,807 4,322
Services   6,959   5,098   12,979   9,513
Total cost of revenue   9,034   7,544   16,786   13,835
Gross profit 29,408 23,795 53,172 46,089
Operating expenses(1, 2):
Research and development 11,618 6,646 21,579 13,004
Sales and marketing 25,065 18,281 48,100 35,828
General and administrative 7,622 4,597 16,027 8,980
Amortization of purchased intangibles   361   –   565   –
Total operating expenses   44,666   29,524   86,271   57,812
Loss from operations (15,258) (5,729) (33,099) (11,723)
Other expense, net   (215)   (55)   (369)   (102)
Loss before provision (benefit) for income taxes (15,473) (5,784) (33,468) (11,825)
Provision (Benefit) for income taxes   (35)   261   (406)   415
Net loss (15,438) (6,045) (33,062) (12,240)
Add: Loss attributable to noncontrolling interest   –   130   213   266
Net loss attributable to Imperva, Inc. stockholders $ (15,438) $ (5,915) $ (32,849) $ (11,974)
 

Net loss per share of common stock attributable to Imperva, Inc. stockholders, basic and diluted

$ (0.60) $ (0.24) $ (1.29) $ (0.50)
 

Shares used in computing net loss per share of common stock, basic and diluted

  25,782   24,171   25,545   24,039
 
(1) Stock-based compensation expense as included in above:
Cost of revenue $ 529 $ 255 $ 903 $ 468
Research and development 2,190 720 3,982 1,386
Sales and marketing 3,209 1,643 5,639 2,976
General and administrative   2,737   974   4,807   1,615
Total stock-based compensation expense $ 8,665 $ 3,592 $ 15,331 $ 6,445
 
(2) Acquisition-related expense as included in above:
Cost of revenue – – 156 –
General and administrative   –   –   1,243   –
Total acquisition-related expense $ – $ – $ 1,399 $ –
 
 
IMPERVA, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
   
As of As of
Jun 30 Dec 31,
2014 2013
Assets
Current assets:
Cash and cash equivalents $ 62,990 $ 76,704
Short-term investments 36,489 38,381
Restricted cash, current 57 34
Accounts receivable, net 33,604 44,446
Inventory 324 512
Deferred tax assets 374 341
Prepaid expenses and other current assets 3,398 3,972
Total current assets 137,236 164,390
 
Property and equipment, net 6,732 5,475
Goodwill 34,972 –
Purchased intangible assets, net 10,103 –
Severance pay fund 4,599 4,140
Restricted cash 1,575 1,252
Deferred tax assets 42 42
Other assets 719 1,192
Total assets $ 195,978 $ 176,491
 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable $ 3,298 $ 3,948
Accrued compensation and benefits 12,235 12,930
Accrued and other current liabilities 4,369 3,961
Deferred revenue 42,206 40,337
Total current liabilities 62,108 61,176
 
Other liabilities 10,129 1,993
Deferred revenue 21,936 22,715
Accrued severance pay 5,078 4,385
Total liabilities 99,251 90,269
 
Stockholders’ equity:
Common stock 2 2
Additional paid-in capital 228,602 187,957
Accumulated deficit (131,544) (98,695)
Accumulated other comprehensive loss (333) (428)
Total Imperva, Inc. stockholders’ equity 96,727 88,836
Noncontrolling interest – (2,614)
Total stockholders’ equity 96,727 86,222
Total liabilities and stockholders’ equity $ 195,978 $ 176,491
 
 
IMPERVA, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
   
For the Six Months Ended
Jun 30 Jun 30
2014 2013
 
Cash flows from operating activities:
Net loss $ (33,062) $ (12,240)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

Depreciation and amortization 1,688 1,269
Stock-based compensation 15,331 6,445
Amortization of acquired intangible assets 565 –

Amortization of premiums/accretion of discounts on short-term investments

217 383
Changes in operating assets and liabilities:
Accounts receivable, net 10,842 8,489
Inventory 188 (40)
Prepaid expenses and other assets 1,207 (404)
Accounts payable (928) (16)
Accrued compensation and benefits (884) 1,350
Accrued and other liabilities (88) (390)
Severance pay, net 234 65
Deferred revenue 1,090 2,012
Deferred tax assets (33) (18)
Other – (8)
Net cash provided by (used in) operating activities (3,633) 6,897
Cash flows from investing activities:
Purchase of short-term investments (11,615) (27,026)
Proceeds from sales/maturities of short-term investments 13,585 29,361
Net purchases of property and equipment (2,845) (1,202)
Change in restricted cash (346) 59
Acquisitions, net of cash acquired (12,083) –
Net cash provided by (used in) investing activities (13,304) 1,192
Cash flows from financing activities:
Proceeds from issuance of common stock, net of repurchases 3,223 2,893
Net cash provided by financing activities 3,223 2,893
Effect of exchange rate changes on cash – (162)
Net increase (decrease) in cash and cash equivalents (13,714) 10,820
 
Cash and cash equivalents at beginning of period $ 76,704 $ 59,201
Cash and cash equivalents at end of period $ 62,990 $ 70,021
 
 
IMPERVA, INC. AND SUBSIDIARIES
(Reconciliation of GAAP to Non-GAAP Measures)
(In thousands, except per share amounts)
(Unaudited)
       
 
 
For the Three Months Ended For the Six Months Ended
Jun 30 Jun 30 Jun 30 Jun 30
  2014   2013   2014   2013
 
GAAP operating loss $ (15,258) $ (5,729) $ (33,099) $ (11,723)
Plus:
Stock-based compensation expense 8,665 3,592 15,331 6,445
Acquisition-related expense – – 1,399 –
Amortization of purchased intangibles   361   –   565   –
Non-GAAP operating loss $ (6,232) $ (2,137) $ (15,804) $ (5,278)
 
GAAP net loss attributable to Imperva, Inc. stockholders $ (15,438) $ (5,915) $ (32,849) $ (11,974)
Plus:
Stock-based compensation expense 8,665 3,592 15,331 6,445
Acquisition-related expense – – 1,399 –
Amortization of purchased intangibles   361 –   565 –
Non-GAAP net loss $ (6,412) $ (2,323) $ (15,554) $ (5,529)
 
Weighted average shares outstanding, basic and diluted 25,782 24,171 25,545 24,039
 
Non-GAAP net loss, basic and diluted $ (0.25) $ (0.10) $ (0.61) $ (0.23)
 

Use of Non-GAAP Financial Information

In addition to the reasons stated above, which are generally applicable to each of the items Imperva excludes from its non-GAAP financial measures, Imperva believes it is appropriate to exclude or give effect to certain items for the following reasons:

Stock-Based Compensation: When evaluating the performance of its consolidated results, Imperva does not consider stock-based compensation charges. Likewise, the Imperva management team excludes stock-based compensation expense from its operating plans. In contrast, the Imperva management team is held accountable for cash-based compensation and such amounts are included in its operating plans. Further, when considering the impact of equity award grants, Imperva places a greater emphasis on overall stockholder dilution rather than the accounting charges associated with such grants.

Amortization of Intangible Assets. When analyzing the operating performance of an acquired entity, Imperva’s management focuses on the total return provided by the investment (i.e., operating profit generated from the acquired entity as compared to the purchase price paid) without taking into consideration any allocations made for accounting purposes. Because the purchase price for an acquisition necessarily reflects the accounting value assigned to intangible assets (including acquired technology and goodwill), when analyzing the operating performance of an acquisition in subsequent periods, Imperva’s management excludes the GAAP impact of acquired intangible assets to its financial results. Imperva believes that such an approach is useful in understanding the long-term return provided by an acquisition and that investors benefit from a supplemental non-GAAP financial measure that excludes the accounting expense associated with acquired intangible assets.

In addition, in accordance with GAAP, Imperva generally recognizes expenses for internally-developed intangible assets as they are incurred until technological feasibility is reached, notwithstanding the potential future benefit such assets may provide. Unlike internally-developed intangible assets, however, and also in accordance with GAAP, Imperva generally capitalizes the cost of acquired intangible assets and recognizes that cost as an expense over the useful lives of the assets acquired (other than goodwill, which is not amortized, as required under GAAP). As a result of their GAAP treatment, there is an inherent lack of comparability between the financial performance of internally-developed intangible assets and acquired intangible assets. Accordingly, Imperva believes it is useful to provide, as a supplement to its GAAP operating results, a non-GAAP financial measure that excludes the amortization of acquired intangibles.

Acquisition-related charges: GAAP requires expenses to be recognized for various types of events associated with a business acquisition, such as legal, accounting, advisory and other deal related expenses. These expenses vary significantly and are unique to each transaction. Additionally, Imperva does not acquire businesses on a predictable cycle. Imperva records these acquisition and other transaction costs as operating expenses when they are incurred. Imperva does not include these expenses when considering operating performance, and believes that these acquisition and other transaction costs affect comparability from period to period and that investors benefit from a supplemental non-GAAP financial measure that excludes these expenses.

Imperva excludes stock based compensation, amortization of intangibles and acquisition-related charges from its non-GAAP financial measures primarily because they are non-cash expenses or other expenses that it does not consider part of ongoing operating results when assessing the performance of its business, and the exclusion of these expenses facilitates the comparison of results and business outlook for future periods with results for prior periods in order to better understand the long term performance of its business.

Source: Imperva, Inc.

Investor Relations
Imperva, Inc.
Seth Potter, 646-277-1230
IR@imperva.com
Seth.Potter@icrinc.com